Health Affairs March 22, 2021
Jeffrey Shuren, Timothy Stenzel

High-quality care depends, in part, on advancing technological solutions. As we look ahead, that progress will increasingly include the ability to perform diagnostic and screening tests at home. COVID-19 has obviously accelerated this trend, and the Food and Drug Administration (FDA) is committed to learning from those experiences, to ensure that, going forward, our nation has the capability to provide remote testing both during the next outbreak and as a part of routine patient care.

Technology Development

Facing any novel outbreak, the first kind of test to be developed is typically a molecular diagnostic test that detects the presence of a virus and its genetic material, such as RNA in the case of SARS-CoV-2. That is because such tests are...

Today's Sponsors

Teladoc Health
Premier
TripleTree

Today's Sponsors

SalesSparx
Canton & Company

Today's Sponsor

HLTH

 
Topics: Biotechnology, Digital Health, FDA, Govt Agencies, Health IT, Healthcare System, Home, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Public Health, Technology, Telehealth
Q&A: Jon Laurent, Ph.D., Head of research and development at the Pandemic Response Lab (PRL)
NIH to test repurposing up to 7 drugs to treat COVID-19 symptoms at home
As pandemic enters year 2, mental health burden becomes clearer
Decentralized Clinical Trials: Surviving & Thriving in the Clinical Research World of COVID-19
Key Questions about COVID-19 Vaccine Passports and the U.S.